Tumour necrosis factor alpha--a constitutive protein of bile
Jackson, G.D.; Dai, Y.; Fung, C.; Hansen, P.G.
Advances in Experimental Medicine and Biology 371b: 1083-1086
1995
ISSN/ISBN: 0065-2598 PMID: 7502758 Document Number: 447595
Document emailed within 1 workday
Related Documents
Rémy, A.; Avouac, J.; Gossec, L.; Combe, B. 2011: Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis Clinical and Experimental Rheumatology 29(1): 96-103Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Browne, W.L.; Wilson, W.R.; Baguley, B.C.; Ching, L.M. 1998: Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid Anticancer Research 18(6a): 4409-4413
Cheema, I.R.; Hermann, C.; Postell, S.; Holifield, B. 1999: Effect of tumour necrosis factor-alpha on total myofibrillar and sarcoplasmic protein synthesis and polysomal aggregation in rat skeletal muscles Cytobios 97(386): 133-139
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
An, H-Jin.; Seo, M-Jun.; Choi, I-Young.; Park, R-Kil.; Jeong, S.; Lee, J-Young.; Kim, H-Min.; Um, J-Young.; Hong, S-Heon. 2008: Induction of nitric oxide & tumour necrosis factor-alpha by Psoralea corylifolia Indian Journal of Medical Research 128(6): 752-758
Pang, X.P.; Hershman, J.M.; Smith, V.; Pekary, A.E.; Sugawara, M. 1990: The mechanism of action of tumour necrosis factor-alpha and interleukin 1 on FRTL-5 rat thyroid cells Acta Endocrinologica 123(2): 203-210
Munoz, C.; Olivares, M.; Schlesinger, L.; Lopez, M.; Letelier, A. 1994: Increased in vitro tumour necrosis factor-alpha production in iron deficiency anemia European Cytokine Network 5(4): 401-404
Hofmann, S.; Grasberger, H.; Jung, P.; Bidlingmaier, M.; Vlotides, J.; Janssen, O.E.; Landgraf, R. 2002: The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression European Journal of Medical Research 7(4): 171-176
Jorgensen, C.; Couret, I.; Canovas, F.; Bologna, C.; Brochier, J.; Reme, T.; Lipsky, P.; Sany, J. 1996: Mononuclear cell retention in rheumatoid synovial tissue engrafted in severe combined immunodeficient (SCID) mice is up-regulated by tumour necrosis factor-alpha (TNF-alpha) and mediated through intercellular adhesion molecule-1 (ICAM-1) Clinical and Experimental Immunology 106(1): 20-25
Radhakrishnan, V.V.; Sumi, M.G.; Reuben, S.; Mathai, A.; Nair, M.D. 2003: Circulating tumour necrosis factor alpha and soluble TNF receptors in patients with Guillain-Barre syndrome Indian Journal of Medical Research 117: 216-220
Braczkowski, R.; Zubelewicz, B.; Romanowski, W.; Lissoni, P.; Brivio, F. 1998: Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms Journal of Experimental and Clinical Cancer Research: Cr 17(3): 349-354
Manish, R.; Tripathy, R.; Das, B.K. 2003: Plasma glucose and tumour necrosis factor-alpha in adult patients with severe falciparum malaria Tropical Medicine and International Health: Tm and Ih 8(2): 125-128
Sarno, E.N.; Grau, G.E.; Vieira, L.M.; Nery, J.A. 1991: Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states Clinical and Experimental Immunology 84(1): 103-108
Mauri, J.K.; Lasek, W.; Górska, A.; Switaj, T.; Wamil, M.; Młynarczuk, I.; Kazimierczuk, Z. 2001: Synthesis, structure and tumour necrosis factor-alpha production-enhancing properties of novel adamantylamino heterocyclic derivatives Anti-Cancer Drug Design 16(2-3): 73-80
Kumar, V.; Khosla, R.; Gupta, V.; Sarin, B.C.; Sehajpal, P.K. 2008: Differential association of tumour necrosis factor-alpha single nucleotide polymorphism (-308) with tuberculosis and bronchial asthma National Medical Journal of India 21(3): 120-122
Nieto González, J.C.; Monteagudo Saez, I.; López-Longo, F.J.; Serrano, B.én.; Mata Martínez, C.; Carreño Pérez, L. 2013: Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-α) Clinical and Experimental Rheumatology 31(5): 776-778
Perri, F.; Clemente, R.; Festa, V.; De Ambrosio, C.C.; Quitadamo, M.; Fusillo, M.; Grossi, E.; Andriulli, A. 1999: Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies Italian Journal of Gastroenterology and Hepatology 31(4): 290-294
Zefferino, R.; Piccaluga, S.; Lasalvia, M.; D' Andrea, G.; Margaglione, M.; Ambrosi, L. 2006: Role of tumour necrosis factor alpha and interleukin 1 beta in promoter effect induced by mercury in human keratinocytes International Journal of Immunopathology and Pharmacology 19(4 Suppl): 15-20
Bebök, Z.; Szekeres, G.; Horváth, G.; Duda, E.; Németh, P. 1993: Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use Orvosi Hetilap 134(24): 1303-1307